The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR + @royalmarsdenNHS) featured earlier in a @BBCr4today segment on #immunotherapy. In the UK you can still listen to today's live program
![Higher Scientific Officer - Targeted Therapy Team, Prof Kevin Harrington (ID496) at The Institute of Cancer Research Higher Scientific Officer - Targeted Therapy Team, Prof Kevin Harrington (ID496) at The Institute of Cancer Research](https://www.jobs.ac.uk/images/employer-logos/medium/328.gif?1532708454)
Higher Scientific Officer - Targeted Therapy Team, Prof Kevin Harrington (ID496) at The Institute of Cancer Research
![Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/researchers/kevin-harrington-appearing-on-bbc-panorama.jpg?sfvrsn=a7226f69_2)
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Histological and functional studies of isolated arteries containing contrast agents exposed to high intensity focused ultrasoun
![High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/default-album/the-icr's-professor-kevin-harrington-at-the-cheltenham-science-festival.jpg?sfvrsn=57f36269_0)
High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London
The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel Prize for Physiology or Medicine being awarded to
![Statement about NICE decision on T-VEC for treating inoperable metastatic melanoma | The Royal Marsden Statement about NICE decision on T-VEC for treating inoperable metastatic melanoma | The Royal Marsden](https://rm-d8-live.s3.eu-west-1.amazonaws.com/d8live.royalmarsden.nhs.uk/s3fs-public/styles/hero_standard/public/Prof%20Kev%20Har.jpg?itok=mnjHeltm)
Statement about NICE decision on T-VEC for treating inoperable metastatic melanoma | The Royal Marsden
![The ICR on Twitter: "Professor Kevin Harrington specialises in #HeadAndNeckCancer. He and his team study the use of biologically targeted agents, in combination with treatments such as #Radiotherapy and #Chemotherapy, to target # The ICR on Twitter: "Professor Kevin Harrington specialises in #HeadAndNeckCancer. He and his team study the use of biologically targeted agents, in combination with treatments such as #Radiotherapy and #Chemotherapy, to target #](https://pbs.twimg.com/media/FYrs27nXoAEamGb.png)
The ICR on Twitter: "Professor Kevin Harrington specialises in #HeadAndNeckCancer. He and his team study the use of biologically targeted agents, in combination with treatments such as #Radiotherapy and #Chemotherapy, to target #
![Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/default-album/t-vec-infected-melanoma-cells-(green)_kevin-harrington-embed.jpg?sfvrsn=70547b69_2)
Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London
![The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter](https://pbs.twimg.com/media/DMFIh_3X0AAF17g.jpg)
The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter
![Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/researchers/professor-kevin-harrington-(jon-enoch-for-the-icr-2012).jpg?sfvrsn=a729a68_4)
Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London
![ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/images/default-source/default-album/icr-rmh-clarivate-highly-cited-researchers-2021-2-945x532.tmb-0945x532.jpg?sfvrsn=3d922b69_1)